Ingevity (NYSE:NGVT – Get Free Report) is anticipated to announce its earnings results after the market closes on Wednesday, February 19th. Analysts expect the company to announce earnings of $0.29 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.
Ingevity Stock Performance
Ingevity stock opened at $45.44 on Wednesday. The firm’s fifty day moving average price is $43.53 and its 200-day moving average price is $40.90. The company has a debt-to-equity ratio of 6.52, a quick ratio of 1.04 and a current ratio of 1.76. The stock has a market cap of $1.65 billion, a P/E ratio of -2.93 and a beta of 1.64. Ingevity has a fifty-two week low of $30.90 and a fifty-two week high of $56.29.
Analyst Ratings Changes
Separately, BMO Capital Markets increased their target price on shares of Ingevity from $40.00 to $47.00 and gave the company a “market perform” rating in a report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $52.17.
Ingevity Company Profile
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
Featured Stories
- Five stocks we like better than Ingevity
- 3 Stocks to Consider Buying in October
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- Stock Market Upgrades: What Are They?
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- Learn Technical Analysis Skills to Master the Stock Market
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.